Panagora Asset Management’s Abeona Therapeutics ABEO Stock Holding History

Panagora Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.77M	Buy	527,147 +118,072	+29%	+$733K	0.01%	566
2026 Q2	$2.53M	Buy	409,075 +209,930	+105%	+$1.15M	0.01%	588
2026 Q1	$892K	Buy	199,145 +32,434	+19%	+$162K	﹤0.01%	734
2025 Q4	$879K	Buy	166,711 +6,154	+4%	+$31K	﹤0.01%	755
2025 Q3	$848K	Buy	+160,557	New	+$1.02M	﹤0.01%	693
2021 Q3	–	Sell	-105	Closed	-$4K	–	1696
2021 Q2	$4K	Sell	105 -687	-87%	-$28K	﹤0.01%	2514
2021 Q1	$37K	Buy	792 +687	+654%	+$37.8K	﹤0.01%	2234
2020 Q4	$4K	Buy	+105	New	+$3.58K	﹤0.01%	2504
2020 Q3	–	Sell	-145	Closed	-$11K	–	2690
2020 Q2	$11K	Buy	+145	New	+$10K	﹤0.01%	2230

Other funds holding ABEO

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Panagora Asset Management's ABEO Position: Q3 2026 in Review

Panagora Asset Management increased its Abeona Therapeutics (ABEO) stake by 29% in Q3 2026, buying an estimated $733K and bringing the position to 527,147 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #566.

Panagora Asset Management first reported a position in ABEO in Q2 2020 and has held it in 9 quarters since. 52 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

Panagora Asset Management held 527,147 shares of Abeona Therapeutics worth $2.77M as of Q3 2026.
Panagora Asset Management bought 118,072 Abeona Therapeutics shares in Q3 2026, an estimated $733K.
Abeona Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q3 2026, its #566 holding.
Panagora Asset Management first reported a position in Abeona Therapeutics in Q2 2020 and has held it in 9 quarters since.
52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Panagora Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.